187 results
Page 3 of 10
8-K
EX-99.1
je5g2uknl486qep
14 Jan 21
Departure of Directors or Certain Officers
7:30am
SC TO-T
EX-99
40yxby
22 Dec 20
Third party tender offer statement
7:07am
8-K
EX-99.1
f3sde 5tk1f0rv4ddm
15 Dec 20
Lilly Announces 2021 Financial Guidance, Updates 2020 Guidance
7:27am
SC TO-C
EX-99.1
4gksigv1d
15 Dec 20
Information about tender offer
6:29am
8-K
EX-99.1
k2qbtl
27 Oct 20
Lilly Reports Third-Quarter Financial Results, Updates Guidance
7:50am
8-K
EX-99.1
d0aczr1m
30 Jul 20
Lilly Reports Second-Quarter Financial Results, Raises EPS Guidance
7:03am
PX14A6G
yu7 rfgxf3grtz3nwj
27 Apr 20
Letter to shareholders
5:30pm
424B5
k13w33s6ga41k36qb
27 Apr 20
Prospectus supplement for primary offering
4:07pm
424B5
97oal
24 Apr 20
Prospectus supplement for primary offering
8:49am
8-K
EX-99.1
8t204w5j37b5 f3pm
23 Apr 20
Lilly Reports Strong First-Quarter Financial Results, Adjusts EPS Guidance
8:02am
SC TO-T/A
EX-99
1gs4i
20 Feb 20
Third party tender offer statement (amended)
9:12am
8-K
EX-99.1
6okkw9l3ef
30 Jan 20
Lilly Reports Strong Fourth-Quarter and Full-Year 2019 Financial Results, Updates 2020 Guidance for Pending Dermira Acquisition
6:29am
SC TO-T
EX-99
ugpbkbyazvb
22 Jan 20
Third party tender offer statement
7:04am
SC TO-C
EX-99.1
0xqfbi2xu
10 Jan 20
Information about tender offer
6:56am